3.68
price down icon1.60%   -0.06
after-market Dopo l'orario di chiusura: 3.71 0.03 +0.82%
loading

Polypid Ltd Borsa (PYPD) Ultime notizie

pulisher
09:47 AM

Is PolyPid Ltd. a good long term investmentExceptional earning trajectories - PrintWeekIndia

09:47 AM
pulisher
06:28 AM

Is PolyPid Ltd. stock a good hedge against inflationFree Stock Selection - jammulinksnews.com

06:28 AM
pulisher
06:18 AM

Will PolyPid Ltd. stock benefit from interest rate changesRapid wealth multiplication - jammulinksnews.com

06:18 AM
pulisher
02:10 AM

Why PolyPid Ltd. stock attracts strong analyst attentionReal Trader Insights - Newser

02:10 AM
pulisher
Jul 23, 2025

PolyPid Ltd. Stock Analysis and ForecastConsistently exceptional gains - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

What analysts say about PolyPid Ltd. stockUnmatched profit growth - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 23, 2025

What drives PolyPid Ltd. stock priceConsistent high-yield stocks - Autocar Professional

Jul 23, 2025
pulisher
Jul 16, 2025

PolyPid Launches Long-Acting GLP-1 Delivery Platform for Diabetes Market - The Globe and Mail

Jul 16, 2025
pulisher
Jul 16, 2025

PYPD: Positive Topline Data From D-PLEX₁₀₀ Trial Contributes to Multiple Subsequent Benefits - Yahoo Finance

Jul 16, 2025
pulisher
Jul 15, 2025

PolyPid's Game-Changing 60-Day GLP-1 Platform Could Disrupt $100B Weight Loss Market - openPR.com

Jul 15, 2025
pulisher
Jul 15, 2025

How PolyPid Ltd. stock performs during market volatilityFree Exclusive Stock Market Insights - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

What makes PolyPid Ltd. stock price move sharplyFree Exclusive Stock Market Insights - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Analysts Set PolyPid Ltd. (NASDAQ:PYPD) Price Target at $11.80 - Defense World

Jul 15, 2025
pulisher
Jul 15, 2025

Finance Herald Publishes Coverage of PolyPid's Groundbreaking New 60-Day GLP-1 Delivery Tech - The Manila Times

Jul 15, 2025
pulisher
Jul 15, 2025

PolyPid unveils 60-day GLP-1 delivery platform for diabetes treatment - Investing.com Australia

Jul 15, 2025
pulisher
Jul 15, 2025

PolyPid Unveils a Long-Acting GLP-1 Receptor Agonists - GlobeNewswire

Jul 15, 2025
pulisher
Jul 15, 2025

Revolutionary 60-Day GLP-1 Injection Could Replace Weekly Diabetes Treatments, PolyPid Announces - Stock Titan

Jul 15, 2025
pulisher
Jul 12, 2025

PolyPid (NASDAQ:PYPD) Raised to “Hold” at Wall Street Zen - Defense World

Jul 12, 2025
pulisher
Jul 09, 2025

PolyPid (NASDAQ:PYPD) Stock Price Down 0.6% – Here’s What Happened - Defense World

Jul 09, 2025
pulisher
Jul 06, 2025

Is PolyPid Stock Undervalued? (NASDAQ: PYPD) - newsblaze.com

Jul 06, 2025
$23.40
price down icon 0.97%
$36.67
price up icon 0.22%
$103.95
price up icon 0.42%
$28.67
price up icon 3.99%
$115.31
price up icon 0.65%
biotechnology ONC
$291.47
price down icon 1.68%
Capitalizzazione:     |  Volume (24 ore):